small molecule

ALECENSA

ALECTINIB HYDROCHLORIDE

Loss of exclusivityApril 2035latest FDA-listed patent expiry

CompanyHOFFMANN-LA ROCHE INC

Drug detail

Brand name	ALECENSA
Active ingredient	ALECTINIB HYDROCHLORIDE
Strength	EQ 150MG BASE
Dosage form	CAPSULE
Route	ORAL
Modality	Small molecule
FDA approval	December 2015
Marketing status	RX

Listed patents

Patent	Expires	Type
10350214	April 2035	product
11433076	April 2035	product
9365514	March 2032	product
9126931	May 2031	substance
9440922	June 2030	product

Regulatory exclusivity

Code	Expires
ODE-477	April 2031
I-947	April 2027

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from HOFFMANN-LA ROCHE INC